These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33228199)

  • 1. Wnt/β-Catenin Target Genes in Colon Cancer Metastasis: The Special Case of L1CAM.
    Cheriyamundath S; Ben-Ze'ev A
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33228199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wnt Target Gene L1 in Colon Cancer Invasion and Metastasis.
    Haase G; Gavert N; Brabletz T; Ben-Ze'ev A
    Cancers (Basel); 2016 May; 8(5):. PubMed ID: 27187476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.
    Shvab A; Haase G; Ben-Shmuel A; Gavert N; Brabletz T; Dedhar S; Ben-Ze'ev A
    Oncogene; 2016 Feb; 35(5):549-57. PubMed ID: 25915847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
    Basu S; Gavert N; Brabletz T; Ben-Ze'ev A
    Cancer Lett; 2018 Jun; 424():9-18. PubMed ID: 29551399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of cathepsin D is required for L1-mediated colon cancer progression.
    Basu S; Cheriyamundath S; Gavert N; Brabletz T; Haase G; Ben-Ze'ev A
    Oncotarget; 2019 Aug; 10(50):5217-5228. PubMed ID: 31497251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis.
    Shapiro B; Tocci P; Haase G; Gavert N; Ben-Ze'ev A
    Oncotarget; 2015 Oct; 6(33):34389-401. PubMed ID: 26399194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
    Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
    Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
    Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
    J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARHGAP25: A negative regulator of colorectal cancer (CRC) metastasis via the Wnt/β-catenin pathway.
    Tao L; Zhu Y; Gu Y; Zheng J; Yang J
    Eur J Pharmacol; 2019 Sep; 858():172476. PubMed ID: 31228451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISG15 induction is required during L1-mediated colon cancer progression and metastasis.
    Cheriyamundath S; Basu S; Haase G; Doernberg H; Gavert N; Brabletz T; Ben-Ze'ev A
    Oncotarget; 2019 Dec; 10(67):7122-7131. PubMed ID: 31903170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Necessary Role for Increased Biglycan Expression during L1-Mediated Colon Cancer Progression.
    Saha A; Cheriyamundath S; Kumar A; Gavert N; Brabletz T; Ben-Ze'ev A
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
    Lee SK; Hwang JH; Choi KY
    Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells.
    Gavert N; Ben-Shmuel A; Lemmon V; Brabletz T; Ben-Ze'ev A
    J Cell Sci; 2010 Jun; 123(Pt 12):2135-43. PubMed ID: 20501702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway.
    Hu TH; Yao Y; Yu S; Han LL; Wang WJ; Guo H; Tian T; Ruan ZP; Kang XM; Wang J; Wang SH; Nan KJ
    Cancer Lett; 2014 Nov; 354(2):417-26. PubMed ID: 25150783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression.
    Cheriyamundath S; Kumar A; Gavert N; Brabletz T; Ben-Ze'ev A
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression.
    Ben-Shmuel A; Shvab A; Gavert N; Brabletz T; Ben-Ze'ev A
    Oncogene; 2013 Jul; 32(27):3220-30. PubMed ID: 22869145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
    Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer.
    Li Q; Lai Q; He C; Fang Y; Yan Q; Zhang Y; Wang X; Gu C; Wang Y; Ye L; Han L; Lin X; Chen J; Cai J; Li A; Liu S
    J Exp Clin Cancer Res; 2019 Aug; 38(1):334. PubMed ID: 31370857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.